EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biology-guided Radiotherapy

Joshua P. Schiff, Justin Park, Shahed N. Badiyan, Bin Cai, Henry S. Park, Arya Amini, Lucas Kas Vitzthum, Neal McCall, Eric L. Chang, Jason C. Ye

Clinical Nuclear Medicine Open · 2025

DOI: 10.1097/nm9.0000000000000027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2025. Verfasst von Joshua P. Schiff und 9 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advancements in technology allowing the advent of stereotactic body radiation therapy (SBRT) and inclusion of PET imaging into radiation oncology workflows have shaped modern radiation oncology treatment planning and delivery. The X1 (RefleXion Medical) is a novel radiation delivery device that is equipped with PET arcs, which guide the linear accelerator (linac) portion of the machine, allowing for the delivery of biology-guided radiotherapy (BgRT) in which the PET signal is actively used to target external beam radiotherapy during treatment delivery. We provide a review of the X1 machine and BgRT workflow, as well as early cases delivered on the X1 device. Patients and Methods: The X1 device and BgRT workflow are described in detail. Key components of the machine include its two 90-degree PET detector arcs, which collect PET data in real time, enabling the delivery of BgRT. The BgRT workflow is unique from the standard radiation oncology workflow in that radiotracer injections and X1 PET scans are performed as a part of treatment planning, as well as immediately before and during each fraction of BgRT for treatment guidance.

Results

We describe 4 of the first BgRT cases including successful treatments of lung (peripheral and central) and bone tumors, as well as unsuccessful treatment of a bone metastasis.

Conclusions

BgRT is an emerging treatment paradigm in which PET signals are used in real time to direct external beam radiotherapy. Currently cleared for FDG-guidance for lung and bone tumors, further research is needed to expand the indications and availability of various radiotracers for BgRT delivery.

Zitieren

APA

Schiff, J. P., Park, J., Badiyan, S. N., Cai, B., Park, H. S., Amini, A., Vitzthum, L. K., McCall, N., Chang, E. L., & Ye, J. C. (2025). Biology-guided Radiotherapy. Clinical Nuclear Medicine Open. https://doi.org/10.1097/nm9.0000000000000027

Vancouver

Schiff JP, Park J, Badiyan SN, Cai B, Park HS, Amini A, et al. Biology-guided Radiotherapy. Clinical Nuclear Medicine Open. 2025. doi:10.1097/nm9.0000000000000027

BibTeX
@article{Schiff2025,
  author = {Schiff, Joshua P. and Park, Justin and Badiyan, Shahed N. and Cai, Bin and Park, Henry S. and Amini, Arya and Vitzthum, Lucas Kas and McCall, Neal and Chang, Eric L. and Ye, Jason C.},
  title = {Biology-guided Radiotherapy},
  journal = {Clinical Nuclear Medicine Open},
  year = {2025},
  doi = {10.1097/nm9.0000000000000027}
}
Kostenlos starten →